Laser Capture Microdissection with Genome-Wide Expression Profiling Displayed Gene Expression Signatures in Endometrioid Endometrial Cancer

REFERENCES

• Haidopoulos D, Simou M, Akrivos N, Rodolakis A, Vlachos G, Fotiou S, Sotiropoulou M, Thomakos N, Biliatis I, Protopappas A, Antsaklis A. Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet Gynecol Scand 2010;89:1326–1330.
   PubMed Web of Science ®Google Scholar
• Kok Ying N, Ganesalingam M, Sabaratnam S. Cancer incidence in peninsular Malaysia. In National Cancer Registry, G Lim Chin Chye, S Rampal, and H Yahaya (eds.). Kuala Lumpur, Malaysia: National Cancer Registry, 2008, 1–286.
   Google Scholar
• Cancer Statistics Branch, National Cancer Institute. Surveillance, Epidemiology and End Results. Available at: http://seer.cancer.gov/statfacts/
   Google Scholar
• Ueda Y, Enomoto T, Egawa-Takata T, Miyatake T, Yoshino K, Fujita M, Matsuzaki S, Yokoyama T, Miyoshi Y, Kimura T. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up. Int J Clin Oncol 2008;15:406–412.
   Web of Science ®Google Scholar
• Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colás E, Llauradó M, Alazzouzi H, Planagumá J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventós J. Novel molecular profiles of endometrial cancer –new light through old windows. J Steroid Biochem Mol Biol 2008;108:221–229.
   PubMed Web of Science ®Google Scholar
• Lilja JF, Wu D, Reynolds RK, Lin J. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells. Anticancer Res 2001;21:1969–1974.
   PubMed Web of Science ®Google Scholar
• Zhu X, Kwon CH, Schlosshauer PW, Ellenson LH, Baker SJ. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res 2001;61:4569–4575.
   PubMed Web of Science ®Google Scholar
• Maxwell GL, Chandramouli GV, Dainty L, Litzi TJ, Berchuck A, Barrett JC, Risinger JI. Microarray analysis of endometrial carcinomas and mixed Mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res 2005;11:4056–4066.
   PubMed Web of Science ®Google Scholar
• Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels. Gynecol Oncol 2006;101:305–310.
   PubMed Web of Science ®Google Scholar
• Kabbarah O, Mallon MA, Pfeifer JD, Goodfellow PJ. Transcriptional profiling endometrial carcinomas microdissected from DES-treated mice identifies changes in gene expression associated with estrogenic tumor promotion. Int J Cancer 2006;119:1843–1849.
   PubMed Web of Science ®Google Scholar
• Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J. Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecol Oncol 2004;92:719–725.
   PubMed Web of Science ®Google Scholar
• Saghir FS, Rose IM, Dali AZ, Shamsuddin Z, Jamal AR, Mokhtar NM. Gene expression profiling and cancer-related pathways in type I endometrial carcinoma. Int J Gynecol Cancer 2010;20:724–731.
   PubMed Web of Science ®Google Scholar
• Draghici S, Khatri P, Eklund AC, Szallasi Z. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 2006;22:101–109.
   PubMed Web of Science ®Google Scholar
• Esposito G. Complementary techniques: laser capture microdissection –increasing specificity of gene expression profiling of cancer specimens. Adv Exp Med Biol 2007;593:54–65.
   PubMed Web of Science ®Google Scholar
• Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol 2006;101:209–213.
   PubMed Web of Science ®Google Scholar
• Wong YF, Cheung TH, Lo KW, Yim SF, Siu NSS, Chan SCS, Ho TWF, Wong KWY, Yu MY, Wang VW, Li C, Gardner GJ, Bonome T, Johnson WB, Smith DI, Chung TKH, and Birrer MJ. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 2007;26:1971–1982.
   PubMed Web of Science ®Google Scholar
• Du XL, Jiang T, Zhao WB, Wang F, Wang GL, Cui M, Wen ZQ. Gene alterations in tumor-associated endothelial cells from endometrial cancer. Int J Mol Med 2008;22:619–632.
   PubMed Web of Science ®Google Scholar
• McGrath M, Lee IM, Buring J, De Vivo I. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecol Oncol 2010;120:174–178.
   Web of Science ®Google Scholar
• Osawa A, Kato M, Matsumoto E, Iwase K, Sugimoto T, Matsui T, Ishikura H, Sugano S, Kurosawa H, Takiguchi M, Seki N. Activation of genes for growth factor and cytokine pathways late in chondrogenic differentiation of ATDC5 cells. Genomics 2006;88:52–64.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma Y, Lu B, Xu E, Huang Q, Lai M. Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study. Exp Biol Med (Maywood) 2007;232:1152–1159.
   PubMed Web of Science ®Google Scholar
• Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 2002;22:1184–1193.
   PubMed Web of Science ®Google Scholar
• Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C, Christensen E, Schmidt SS, Roche PC, Smith DI, Thibodeau SN. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 2000;26:146–147.
   PubMed Web of Science ®Google Scholar
• Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 2001;61:8247–8255.
   PubMed Web of Science ®Google Scholar
• Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008;452:187–193.
   PubMed Web of Science ®Google Scholar
• Patani N, Jiang W, Mansel R, Newbold R, Mokbel K. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009;9:18.
   PubMed Web of Science ®Google Scholar
• Li QQ, Chen ZQ, Cao XX, Xu JD, Xu JW, Chen YY, Wang WJ, Chen Q, Tang F, Liu XP, Xu ZD. Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ 2011;18:16–25.
   PubMed Web of Science ®Google Scholar
• Fan X, Ross DD, Arakawa H, Ganapathy V, Tamai I, Nakanishi T. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Biochem Pharmacol 2010;80:811–818.
   PubMed Web of Science ®Google Scholar
• Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci 2008.
   PubMed Web of Science ®Google Scholar
• Nawashiro H, Otani N, Uozumi Y, Ooigawa H, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y. High expression of L-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol 2005;22: 89–91.
   PubMedGoogle Scholar
• Gielen SC, Hanekamp EE, Blok LJ, Huikeshoven FJ, Burger CW. Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling? J Soc Gynecol Investig 2005;12:58–64.
   PubMedGoogle Scholar
• Pavelic J, Radakovic B, Pavelic K. Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. Gynecol Oncol 2007;105: 727–735.
   PubMed Web of Science ®Google Scholar